Comparing High-Intensity Versus Low-to Moderate-Intensity Statin Therapy in Korean Patients with Acute Myocardial Infarction
Journal of Lipid and Atherosclerosis
;
: 97-104, 2014.
Article
Dans Coréen
| WPRIM
| ID: wpr-60464
ABSTRACT
OBJECTIVE:
The aim of this study is to compare the clinical benefits between high-intensity and low-to moderate-intensity statin therapy in patients with acute myocardial infarction (AMI).METHODS:
A total of 1,230 patients in the Korea AMI Registry (KAMIR) were enrolled. Patients were divided into two groups according to the dosage of statin for the secondary prevention after AMI. The primary endpoint was composite of major adverse cardiac events (MACEs) including cardiac death, non-fatal MI, repeat revascularization during the 12 months of clinical follow-up.RESULT:
The primary endpoint occurred in 101 patients (11.3%) from the low-to moderate-intensity statin group and 45 patients (13.4%) from the high-intensity statin group. The cumulative incidence of MACEs during 12-month follow-up was not significantly different between the two groups (p=0.323). After multi-variate analysis, MACEs-free survival rate was not significantly different between the two groups.CONCLUSION:
High-intensity statin therapy did not show additional clinical benefit over low-to moderate-intensity statin therapy after AMI.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Incidence
/
Taux de survie
/
Études de suivi
/
Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase
/
Mort
/
Prévention secondaire
/
Corée
/
Infarctus du myocarde
Type d'étude:
Etude d'incidence
/
Étude observationnelle
/
Étude pronostique
Limites du sujet:
Humains
Pays comme sujet:
Asie
langue:
Coréen
Texte intégral:
Journal of Lipid and Atherosclerosis
Année:
2014
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS